Metraipolis › archive › dc_9ada196a57be

Anti-diabetic retinopathy molecular mechanism of Dihuang Yinzi: insights from network pharmacology, metabolomics, and microbiome analysis — Europe PMC PMID:42221101

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42221101
DOI
10.3389/fmed.2026.1793936
License (as archived)
solo-consultazione
Archived
2026-10-08T16:29:40.747Z
SHA-256 of the archived text
c11ab52c744239a5d515b1d8a165e38339d210918ea39c5cedfe15bcd5e9c0d2
Stable URL of this page
https://metraipolis.com/documento/dc_9ada196a57be

How to cite

Anti-diabetic retinopathy molecular mechanism of Dihuang Yinzi: insights from network pharmacology, metabolomics, and microbiome analysis — Europe PMC PMID:42221101 — Europe PMC (en), https://europepmc.org/article/MED/42221101 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9ada196a57be (Metraipolis archive dc_9ada196a57be, sha256 c11ab52c744239a5d515b1d8a165e38339d210918ea39c5cedfe15bcd5e9c0d2)
BibTeX
@misc{dc9ada196a57be,
  title = {Anti-diabetic retinopathy molecular mechanism of Dihuang Yinzi: insights from network pharmacology, metabolomics, and microbiome analysis — Europe PMC PMID:42221101},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42221101},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9ada196a57be; sha256 c11ab52c744239a5d515b1d8a165e38339d210918ea39c5cedfe15bcd5e9c0d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42221101. Agents can read the archived copy with the MCP tool read_document.